NSE filing, NSE: ZYDUSLIFE. Summary written from the filing by ALFA Finder's alert engine.
Zydus Lifesciences Ltd: key numbers
- Share price
- ₹1,245.50
- Market cap
- ₹1,25,326 Cr
- Revenue (annual)
- ₹27,148 Cr
- Net profit (annual)
- ₹5,040 Cr
- P/E (TTM)
- 27.8×Sector 45.9×
- Promoter holding
- 75.01%+0.00% QoQ
- FII holding
- 7.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zydus Lifesciences Ltd
All →Zydus Lifesciences Partnership
Zydus Lifesciences' division Zylidac Bio partnered with Prolific Machines to scale their next-generation biologics manufacturing platform for GMP production.
Zydus Lifesciences Regulatory Approval
Zydus Lifesciences received USFDA approval for its Estradiol-Levonorgestrel Transdermal System ANDA, designated as a CGT. The product is eligible for 180-day exclusivity upon first commercial marketing.
Zydus Lifesciences Board Meeting Date
Zydus Lifesciences intimated a board meeting on 4 Nov 2026 to approve unaudited Q1/H1 FY27 results. Trading window remains closed until 6 Nov 2026.
Zydus Lifesciences Other Announcement
Zydus Lifesciences Limited has been assigned an ESG rating of 71 by NSRAL for the financial year 2026. This unsolicited rating reflects the company's sustainability performance.
Zydus Lifesciences Capacity Expansion: ₹190 Cr Investment
Zydus' JV with Sunshine Healthcare signed a BOI agreement to establish a pharma plant in Sri Lanka. Investment exceeds USD 20 million (~₹190 Cr), targeting 2028.
- Value
- ₹190.0 Cr
Zydus Lifesciences Business Update
Zydus Lifesciences presented post-hoc analysis from its EPICS-III clinical trial for Saroglitazar at ACG 2026. The drug remains under regulatory review for PBC treatment.
Other management change announcements
All →Shanthala FMCG Products Management Change
Shanthala FMCG removed CFO Yogish Mallya over alleged misappropriation of funds and appointed Ratnakar Rai as CFO. Both changes are effective 31 October 2026.
Vahh Chemicals Management Change
VAHH Chemicals Limited appointed Ms. Shubhangi Rajesh Gadia as Company Secretary and Compliance Officer, effective 01 November 2026. The appointment was approved at a board meeting held on 31 October 2026.
Capital India Finance Management Change
Capital India Finance reports that Senior Management Personnel Ravindran Menon resigned, ceasing to be associated with the company from close of business on 31 October 2026. The resignation letter is enclosed.
Bank of Maharashtra Management Change
Bank of Maharashtra disclosed that Chief General Manager Dinkar Sankpal ceased to hold the post at close of 31 October 2026 on superannuation. This is a senior management departure.
Seksaria Finance Management Change
Seksaria Finance's Company Secretary and Compliance Officer, Amar Hasmukh Trivedi, resigned effective close of business on 31 October 2026. The board accepted the resignation at its 29 October 2026 meeting.
Nova Iron & Steel Management Change
Nova Iron and Steel appointed Palak Jindal as independent director and re-appointed Hardev Chand Verma as non-executive director. Both changes are board-level management updates.